glp-1-directed nmda receptor antagonism for obesity treatment GLP-1 Agonists and Research to Treat Overeating and Substance Use Disorders Treating obesity using glucagon-like peptide-1-directed

A balanced approach that combines appropriate nutrition, regular physical activity, and medical guidance can help patients maximize the benefits of their weight loss treatment while developing sustainable lifestyle changes

These enhanced effects are attributed to the synergistic effect of the intestinal insulinotropic and PPAR pathways in the brain and adipose tissue

D., Le, T

Retrieved 24 March 2020

The coexistence of both diseases not only induced a systemic pro-inflammatory state leading to coronary microvascular endothelial inflammation and resulting in myocardial dysfunction, but also induced a persistent pro-inflammatory state causing cardiac fibrosis that led to myocardial necrosis [7,8,9,10]